NCT06019923 Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
| NCT ID | NCT06019923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women's Hospital School Of Medicine Zhejiang University |
| Condition | Ovarian Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-26 |
| Primary Completion | 2026-09-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-10-26 with a primary completion date of 2026-09-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ovarian cancer is a highly lethal gynecological malignancy, often diagnosed at an advanced stage, with high rates of recurrence within 1-2 years after frontline treatment. Current guidelines recommend monitoring tumor markers CA125 and HE4 for disease progression, but these markers may not detect recurrence or disease progression when their levels are below the detection limit. Therefore, there is a need to identify new prognostic biomarkers and monitor their dynamic changes for effective risk stratification and personalized treatment in patients with ovarian cancer
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 75 years; * Pathological diagnosis of high-grade serous ovarian cancer; * Newly diagnosed ovarian cancer case without prior neoadjuvant therapy. Exclusion Criteria: * Non-primary (recurrent) patients; * Ovarian cancer patients who have not undergone surgical treatment; * Patients with a history of other malignancies.
Contact & Investigator
Hongyu Xie, phD
PRINCIPAL INVESTIGATOR
Women's Hospital School Of Medicine Zhejiang University
Frequently Asked Questions
Who can join the NCT06019923 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Ovarian Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06019923 currently recruiting?
Yes, NCT06019923 is actively recruiting participants. Contact the research team at xiehongyu@zju.edu.cn for enrollment information.
Where is the NCT06019923 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06019923 clinical trial?
NCT06019923 is sponsored by Women's Hospital School Of Medicine Zhejiang University. The principal investigator is Hongyu Xie, phD at Women's Hospital School Of Medicine Zhejiang University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.